FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “BIORESOLIMUS”, which is offered here for Pharmaceutical preparations, in particular, immunosuppressants and antiproliferates; pharmaceutical preparations for medical purposes, drug preparations, in the nature of polymerdrug preparations and excipient-drug preparations for the treatment of vascular diseases or hollow organ diseases; chemical or pharmaceutical preparations used for medical devices, antiproliferative coatings for medical devices and chemical or pharmaceutical preparations for antiproliferative purposes used for stents and/or drug eluting balloons, in particular, antiproliferative coatings for stents and drug eluting balloons; chemicopharmaceutical preparations for vascular or cardiovascular intervention; drugs for medical purposes, from the limus drug family, in particular limus derivatives, sirolimus, rapamycin, everolimus, umirolimus, zotarolimus, tacrolimus and pimecrolimus for the treatment of vascular diseases or hollow organ diseases; medicines for human purposes for vascular and cardiovascular intervention;.
Its status is currently believed to be active. Its class is unavailable. “BIORESOLIMUS” is believed to be currently owned by “BIOTRONIK AG”.
| Owner: |
BIOTRONIK AG
Owner Details |
|---|---|
| Description: |
Pharmaceutical preparations, in particular, immunosuppressants and antiproliferates; pharmaceutical preparations for medical purposes, drug preparations, in the nature of polymerdrug preparations and excipient-drug preparations for the treatment of vascular diseases or hollow organ diseases; chemical or pharmaceutical preparations used for medical devices, antiproliferative coatings for medical devices and chemical or pharmaceutical preparations for antiproliferative purposes used for stents and/or drug eluting balloons, in particular, antiproliferative coatings for stents and drug eluting balloons; chemicopharmaceutical preparations for vascular or cardiovascular intervention; drugs for medical purposes, from the limus drug family, in particular limus derivatives, sirolimus, rapamycin, everolimus, umirolimus, zotarolimus, tacrolimus and pimecrolimus for the treatment of vascular diseases or hollow organ diseases; medicines for human purposes for vascular and cardiovascular intervention;
|
| Categories: | PHARMACEUTICAL PREPARATIONS |